Breast Cancer Res Treat 2011,125(3):775–784.PubMed 33. Arriagada R, Spielmann M, Koscielny S, Le Chevalier T, Delozier T, Rémé-Saumon M, Ducourtieux M, Tursz T, Hill C: Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1 146 patients with early breast cancer. Acta Oncol 2005,44(5):458–466.PubMed 34. Arriagada RLM, Spielmann M, Mauriac L, Bonneterre J, Namer M, Delozier T, Hill C, Tursz T: Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol 2005,16(3):389–396.PubMed 35. Bedognetti D, Sertoli MR, Pronzato P, Del Mastro L, Venturini

M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Elafibranor mw Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P: Concurrent PF-04929113 molecular weight vs Sequential Adjuvant Chemotherapy and Hormone MK-4827 order Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial. J Natl Cancer Inst 2011,103(20):1529–1539.PubMed 36. Boccardo FRA, Puntoni M, Guglielmini P, Amoroso D, Fini A, Paladini G, Mesiti M, Romeo D, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P: Switching to Anastrozole Versus Continued Tamoxifen Treatment of Early Breast Cancer: Preliminary Results of the Italian Tamoxifen

Anastrozole Trial. J Clin Oncol 2005,23(22):5138–5147.PubMed 37. Burnell M, Levine MN, Chapman JAW, Bramwell V, Gelmon K, Walley B, Vandenberg T, Chalchal H, Albain KS, Perez EA, Rugo H, Pritchard K, O’Brien P, Shepherd LE: Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk

Node-Negative Breast Cancer. J Clin Oncol 2009,28(1):77–82.PubMed 38. Coombes RC, Bliss JM, Espie M, Erdkamp F, Wals ever J, Tres A, Marty M, Coleman RE, Tubiana-Mathieu N, den Boer MO, Wardley A, Kilburn LS, Cooper D, Thomas MW, Reise JA, Wilkinson K, Hupperets P: Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. J Clin Oncol 2011,29(24):3247–3254.PubMed 39. Coombes RC HE, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G, Bliss JM, Van De Velde C, Intergroup Exemestane Study: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004,350(11):1081–1092.PubMed 40.